

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 4.92068479 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 4.92068479 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.53010752 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 4.49425950 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.43351951 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.41335370 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.24493708 |
| 8 | nerve growth factor signaling pathway (GO:0038180) | 4.12785245 |
| 9 | glutamate receptor signaling pathway (GO:0007215) | 4.12490014 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.12183821 |
| 11 | alanine transport (GO:0032328) | 4.03468259 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.00879570 |
| 13 | C4-dicarboxylate transport (GO:0015740) | 3.97598518 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.94363602 |
| 15 | regulation of memory T cell differentiation (GO:0043380) | 3.88406556 |
| 16 | L-amino acid import (GO:0043092) | 3.78000933 |
| 17 | protein localization to synapse (GO:0035418) | 3.73530730 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 3.72380707 |
| 19 | transmission of nerve impulse (GO:0019226) | 3.71996553 |
| 20 | synaptic vesicle maturation (GO:0016188) | 3.70236450 |
| 21 | adult walking behavior (GO:0007628) | 3.68059619 |
| 22 | vocalization behavior (GO:0071625) | 3.54842437 |
| 23 | response to methylmercury (GO:0051597) | 3.54811382 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.54770474 |
| 25 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.54532770 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.53435484 |
| 27 | potassium ion homeostasis (GO:0055075) | 3.52423688 |
| 28 | myelination (GO:0042552) | 3.51731102 |
| 29 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.50878505 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.50242169 |
| 31 | presynaptic membrane organization (GO:0097090) | 3.50173295 |
| 32 | ensheathment of neurons (GO:0007272) | 3.48781686 |
| 33 | axon ensheathment (GO:0008366) | 3.48781686 |
| 34 | neuron recognition (GO:0008038) | 3.47602724 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.46370178 |
| 36 | potassium ion import (GO:0010107) | 3.44575392 |
| 37 | regulation of activation of Janus kinase activity (GO:0010533) | 3.42809320 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.38672330 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.38397367 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.29727920 |
| 41 | auditory receptor cell stereocilium organization (GO:0060088) | 3.29113532 |
| 42 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.28561027 |
| 43 | serotonin metabolic process (GO:0042428) | 3.28484723 |
| 44 | behavioral response to nicotine (GO:0035095) | 3.28123359 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 3.25863377 |
| 46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.25493900 |
| 47 | neuromuscular process controlling posture (GO:0050884) | 3.25166786 |
| 48 | proline transport (GO:0015824) | 3.24988201 |
| 49 | axonal fasciculation (GO:0007413) | 3.21243299 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.19984277 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.15246392 |
| 52 | negative regulation of neurotransmitter transport (GO:0051589) | 3.14979248 |
| 53 | primary amino compound metabolic process (GO:1901160) | 3.13246045 |
| 54 | exploration behavior (GO:0035640) | 3.12753883 |
| 55 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.11751929 |
| 56 | glutamate secretion (GO:0014047) | 3.11579291 |
| 57 | amino acid import (GO:0043090) | 3.11458879 |
| 58 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.10538211 |
| 59 | cell differentiation in hindbrain (GO:0021533) | 3.08151046 |
| 60 | dendritic spine morphogenesis (GO:0060997) | 3.07573070 |
| 61 | long-term memory (GO:0007616) | 3.06324298 |
| 62 | chemosensory behavior (GO:0007635) | 3.03879981 |
| 63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02089436 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 3.02046770 |
| 65 | fucose catabolic process (GO:0019317) | 3.00673509 |
| 66 | L-fucose metabolic process (GO:0042354) | 3.00673509 |
| 67 | L-fucose catabolic process (GO:0042355) | 3.00673509 |
| 68 | regulation of glutamate secretion (GO:0014048) | 3.00052572 |
| 69 | dendrite morphogenesis (GO:0048813) | 2.96694905 |
| 70 | neuromuscular synaptic transmission (GO:0007274) | 2.96070829 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94931427 |
| 72 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.94495472 |
| 73 | membrane depolarization (GO:0051899) | 2.93537757 |
| 74 | regulation of dendritic spine development (GO:0060998) | 2.92493370 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.92463562 |
| 76 | negative regulation of amino acid transport (GO:0051956) | 2.91023655 |
| 77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90120102 |
| 78 | cellular sodium ion homeostasis (GO:0006883) | 2.90035134 |
| 79 | adenosine receptor signaling pathway (GO:0001973) | 2.89577569 |
| 80 | sodium ion export (GO:0071436) | 2.89044041 |
| 81 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.88438145 |
| 82 | postsynaptic membrane organization (GO:0001941) | 2.87274374 |
| 83 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.86724506 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 2.85963247 |
| 85 | neuron remodeling (GO:0016322) | 2.85050475 |
| 86 | neuromuscular process controlling balance (GO:0050885) | 2.84711924 |
| 87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.84390936 |
| 88 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84373687 |
| 89 | multicellular organismal movement (GO:0050879) | 2.83691196 |
| 90 | musculoskeletal movement (GO:0050881) | 2.83691196 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.83671266 |
| 92 | positive regulation of dendritic spine development (GO:0060999) | 2.82074713 |
| 93 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.82067022 |
| 94 | response to nerve growth factor (GO:1990089) | 2.82067022 |
| 95 | regulation of synaptic plasticity (GO:0048167) | 2.81644739 |
| 96 | cerebellar granule cell differentiation (GO:0021707) | 2.81588959 |
| 97 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.81212233 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.79945065 |
| 99 | membrane depolarization during action potential (GO:0086010) | 2.79143452 |
| 100 | myelin maintenance (GO:0043217) | 2.78427080 |
| 101 | regulation of synapse maturation (GO:0090128) | 2.78283671 |
| 102 | regulation of synaptic vesicle transport (GO:1902803) | 2.77755474 |
| 103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77317734 |
| 104 | L-phenylalanine catabolic process (GO:0006559) | 2.77317734 |
| 105 | cellular potassium ion transport (GO:0071804) | 2.77195429 |
| 106 | potassium ion transmembrane transport (GO:0071805) | 2.77195429 |
| 107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.76743031 |
| 108 | positive regulation of cell fate commitment (GO:0010455) | 2.76573020 |
| 109 | fatty acid elongation (GO:0030497) | 2.76509711 |
| 110 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.75696188 |
| 111 | opioid receptor signaling pathway (GO:0038003) | 2.75624259 |
| 112 | regulation of synapse structural plasticity (GO:0051823) | 2.75124742 |
| 113 | regulation of neurotransmitter levels (GO:0001505) | 2.74253213 |
| 114 | neurotransmitter secretion (GO:0007269) | 2.74118686 |
| 115 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.73525709 |
| 116 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.72727163 |
| 117 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.72179509 |
| 118 | acidic amino acid transport (GO:0015800) | 2.72051651 |
| 119 | detection of calcium ion (GO:0005513) | 2.71471052 |
| 120 | nephron epithelium morphogenesis (GO:0072088) | 2.69852497 |
| 121 | nephron tubule morphogenesis (GO:0072078) | 2.69852497 |
| 122 | neurofilament cytoskeleton organization (GO:0060052) | 2.69824638 |
| 123 | negative regulation of protein localization to cell surface (GO:2000009) | 2.69624806 |
| 124 | positive regulation of membrane potential (GO:0045838) | 2.67194627 |
| 125 | cellular ketone body metabolic process (GO:0046950) | 2.67158972 |
| 126 | synaptic vesicle endocytosis (GO:0048488) | 2.66888415 |
| 127 | glycine transport (GO:0015816) | 2.66413662 |
| 128 | mating behavior (GO:0007617) | 2.65664954 |
| 129 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.65253687 |
| 130 | neuronal ion channel clustering (GO:0045161) | 2.65157728 |
| 131 | regulation of vesicle fusion (GO:0031338) | 2.65046396 |
| 132 | long-term synaptic potentiation (GO:0060291) | 2.64444228 |
| 133 | learning (GO:0007612) | 2.64318022 |
| 134 | regulation of neurotransmitter transport (GO:0051588) | 2.63653242 |
| 135 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63442236 |
| 136 | regulation of neurotransmitter secretion (GO:0046928) | 2.63295422 |
| 137 | positive regulation of neurotransmitter transport (GO:0051590) | 2.62580601 |
| 138 | positive regulation of synapse assembly (GO:0051965) | 2.62387874 |
| 139 | potassium ion transport (GO:0006813) | 2.60256069 |
| 140 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.58100333 |
| 141 | membrane hyperpolarization (GO:0060081) | 2.57817233 |
| 142 | adult locomotory behavior (GO:0008344) | 2.57407269 |
| 143 | nucleoside transmembrane transport (GO:1901642) | 2.56965221 |
| 144 | membrane repolarization (GO:0086009) | 2.56150216 |
| 145 | renal tubule morphogenesis (GO:0061333) | 2.55872562 |
| 146 | L-glutamate transport (GO:0015813) | 2.53199988 |
| 147 | activated T cell proliferation (GO:0050798) | 2.52518558 |
| 148 | neurotransmitter transport (GO:0006836) | 2.51450681 |
| 149 | inositol phosphate-mediated signaling (GO:0048016) | 2.50980537 |
| 150 | negative regulation of axonogenesis (GO:0050771) | 2.50787696 |
| 151 | regulation of sensory perception (GO:0051931) | 2.50237249 |
| 152 | startle response (GO:0001964) | 2.48950942 |
| 153 | vesicle transport along microtubule (GO:0047496) | 2.46948660 |
| 154 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.45436315 |
| 155 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.45436315 |
| 156 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.45218878 |
| 157 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.43908893 |
| 158 | regulation of collateral sprouting (GO:0048670) | 2.43542678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.86704874 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56742635 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84755249 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82919366 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71462986 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42254287 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40885844 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40885844 |
| 9 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38604437 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31674228 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28635015 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22865615 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.18869883 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17767893 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17458594 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15977066 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09207886 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08492501 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07109274 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06387531 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03529009 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01007717 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00297028 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00144696 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98177909 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90834814 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.80019981 |
| 28 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77919320 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70942644 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58228339 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55829331 |
| 32 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55222008 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51304072 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50236025 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49690145 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46413857 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45883096 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45729231 |
| 39 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.44800899 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42774664 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42611033 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40867577 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40324986 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40193663 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37965313 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35918996 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35812528 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34850602 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34061687 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32173860 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30053734 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29357093 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29307938 |
| 54 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28451798 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27947595 |
| 56 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25116571 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24767932 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23444563 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22669656 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21154082 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20824829 |
| 62 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18536420 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18160459 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15980935 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15160975 |
| 66 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15078023 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13675901 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13465876 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12130299 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10504950 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09662919 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09179158 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07789641 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07304265 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06907825 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06517605 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05499473 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04828206 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04828206 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04336304 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03892924 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03507603 |
| 83 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02951148 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01034839 |
| 85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00783111 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99820536 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99614719 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99162139 |
| 89 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98859378 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97073399 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96736492 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96667669 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95285048 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93808689 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93592839 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93304862 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93256817 |
| 98 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.91723314 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91244800 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90580041 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89503952 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89471669 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89273073 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88775541 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88568975 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88541604 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88440349 |
| 108 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88379346 |
| 109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88366658 |
| 110 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88123365 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88112187 |
| 112 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87574196 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86921161 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86797490 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86122081 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85465439 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84760895 |
| 118 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83793312 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83631963 |
| 120 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.81795490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.61630596 |
| 2 | MP0003880_abnormal_central_pattern | 4.67714169 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.55915312 |
| 4 | MP0004270_analgesia | 3.35069093 |
| 5 | MP0009745_abnormal_behavioral_response | 3.19393309 |
| 6 | MP0000920_abnormal_myelination | 3.12242676 |
| 7 | MP0002064_seizures | 3.10425357 |
| 8 | MP0003195_calcinosis | 2.91702663 |
| 9 | MP0009046_muscle_twitch | 2.86581012 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.76400293 |
| 11 | MP0002272_abnormal_nervous_system | 2.76097435 |
| 12 | MP0003690_abnormal_glial_cell | 2.64665511 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.58465885 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.56462894 |
| 15 | MP0001486_abnormal_startle_reflex | 2.54029615 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.53831580 |
| 17 | MP0002822_catalepsy | 2.47627309 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.47300281 |
| 19 | MP0010386_abnormal_urinary_bladder | 2.39766156 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.26468779 |
| 21 | MP0003283_abnormal_digestive_organ | 2.25047776 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.12790787 |
| 23 | MP0002736_abnormal_nociception_after | 2.11400449 |
| 24 | MP0005171_absent_coat_pigmentation | 2.08749091 |
| 25 | MP0003329_amyloid_beta_deposits | 2.05071384 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 2.03555599 |
| 27 | MP0000778_abnormal_nervous_system | 1.95862357 |
| 28 | MP0001970_abnormal_pain_threshold | 1.95174281 |
| 29 | MP0004742_abnormal_vestibular_system | 1.92320782 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.90054344 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.88855027 |
| 32 | MP0008569_lethality_at_weaning | 1.86314913 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.84532537 |
| 34 | MP0005409_darkened_coat_color | 1.78584125 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.77736363 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.72801377 |
| 37 | MP0001529_abnormal_vocalization | 1.72254977 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.71912145 |
| 39 | MP0004142_abnormal_muscle_tone | 1.62432589 |
| 40 | MP0004147_increased_porphyrin_level | 1.58954786 |
| 41 | MP0004885_abnormal_endolymph | 1.58009554 |
| 42 | MP0003634_abnormal_glial_cell | 1.57291526 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.56657868 |
| 44 | MP0000955_abnormal_spinal_cord | 1.54546897 |
| 45 | MP0002229_neurodegeneration | 1.52704639 |
| 46 | MP0003633_abnormal_nervous_system | 1.49384001 |
| 47 | MP0001905_abnormal_dopamine_level | 1.48562802 |
| 48 | MP0003632_abnormal_nervous_system | 1.48505173 |
| 49 | MP0002184_abnormal_innervation | 1.46715790 |
| 50 | MP0003631_nervous_system_phenotype | 1.44934378 |
| 51 | MP0000604_amyloidosis | 1.44542279 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.43668255 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.41902367 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.40613645 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.40540539 |
| 56 | MP0005360_urolithiasis | 1.39062360 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.38796208 |
| 58 | MP0004924_abnormal_behavior | 1.37977458 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.37977458 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.36800515 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.35798306 |
| 62 | MP0005332_abnormal_amino_acid | 1.35489766 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.22261104 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.20830971 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.18514291 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.16555826 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.15944612 |
| 68 | MP0003252_abnormal_bile_duct | 1.15828103 |
| 69 | MP0002090_abnormal_vision | 1.13940407 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.12717179 |
| 71 | MP0001944_abnormal_pancreas_morphology | 1.10302886 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.08945060 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 1.08795178 |
| 74 | MP0000566_synostosis | 1.08631851 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.08184889 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.07793065 |
| 77 | MP0003075_altered_response_to | 1.03297713 |
| 78 | MP0001963_abnormal_hearing_physiology | 1.00535056 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.00194559 |
| 80 | MP0004215_abnormal_myocardial_fiber | 0.98538873 |
| 81 | MP0002152_abnormal_brain_morphology | 0.97462685 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.96609955 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.95020085 |
| 84 | MP0001756_abnormal_urination | 0.93650478 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 0.93443416 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.93153232 |
| 87 | MP0003878_abnormal_ear_physiology | 0.93153232 |
| 88 | MP0001984_abnormal_olfaction | 0.91352680 |
| 89 | MP0005410_abnormal_fertilization | 0.91291086 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.90633141 |
| 91 | MP0008874_decreased_physiological_sensi | 0.89487230 |
| 92 | MP0003879_abnormal_hair_cell | 0.87460031 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.87368776 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.87271544 |
| 95 | MP0006082_CNS_inflammation | 0.86927618 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.86658887 |
| 97 | MP0005365_abnormal_bile_salt | 0.86454485 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.85720716 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.85691803 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.84477507 |
| 101 | MP0003045_fibrosis | 0.83415496 |
| 102 | MP0004510_myositis | 0.82844758 |
| 103 | MP0004133_heterotaxia | 0.82730627 |
| 104 | MP0003787_abnormal_imprinting | 0.82388248 |
| 105 | MP0008260_abnormal_autophagy | 0.82182631 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.82158504 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.79985436 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.79485690 |
| 109 | MP0000026_abnormal_inner_ear | 0.79297019 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.77985308 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.77056865 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.75777384 |
| 113 | MP0004858_abnormal_nervous_system | 0.75661950 |
| 114 | MP0005448_abnormal_energy_balance | 0.73953685 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.73867491 |
| 116 | MP0001177_atelectasis | 0.72455149 |
| 117 | MP0008872_abnormal_physiological_respon | 0.71401035 |
| 118 | MP0005253_abnormal_eye_physiology | 0.71345859 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.71315850 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.69513502 |
| 121 | MP0003011_delayed_dark_adaptation | 0.68775219 |
| 122 | MP0005535_abnormal_body_temperature | 0.68139561 |
| 123 | MP0001664_abnormal_digestion | 0.67550333 |
| 124 | MP0001188_hyperpigmentation | 0.67040819 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.66246525 |
| 126 | MP0000747_muscle_weakness | 0.65711560 |
| 127 | MP0004085_abnormal_heartbeat | 0.65545431 |
| 128 | MP0005310_abnormal_salivary_gland | 0.63319412 |
| 129 | MP0004043_abnormal_pH_regulation | 0.62546182 |
| 130 | MP0001851_eye_inflammation | 0.61440461 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.60630170 |
| 132 | MP0003136_yellow_coat_color | 0.58588228 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.55862837 |
| 134 | MP0003303_peritoneal_inflammation | 0.55466914 |
| 135 | MP0004185_abnormal_adipocyte_glucose | 0.54808238 |
| 136 | MP0002295_abnormal_pulmonary_circulatio | 0.53174564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.28237666 |
| 2 | Myokymia (HP:0002411) | 6.08058653 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.04327474 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 4.71661304 |
| 5 | Focal seizures (HP:0007359) | 4.48259539 |
| 6 | Dysmetria (HP:0001310) | 4.16391007 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 4.11822796 |
| 8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.09931449 |
| 9 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.09931449 |
| 10 | Atonic seizures (HP:0010819) | 3.93342702 |
| 11 | Dysdiadochokinesis (HP:0002075) | 3.63089364 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.58864204 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 3.58382054 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.55519974 |
| 15 | Visual hallucinations (HP:0002367) | 3.53815387 |
| 16 | Peripheral hypomyelination (HP:0007182) | 3.42102403 |
| 17 | Scanning speech (HP:0002168) | 3.37470736 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.34341302 |
| 19 | Action tremor (HP:0002345) | 3.30970969 |
| 20 | Broad-based gait (HP:0002136) | 3.27415089 |
| 21 | Intention tremor (HP:0002080) | 3.25180030 |
| 22 | Febrile seizures (HP:0002373) | 3.18059894 |
| 23 | Dialeptic seizures (HP:0011146) | 3.16344447 |
| 24 | Progressive inability to walk (HP:0002505) | 3.14112599 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.10290709 |
| 26 | Spastic gait (HP:0002064) | 3.07417939 |
| 27 | Absence seizures (HP:0002121) | 3.00880330 |
| 28 | Onion bulb formation (HP:0003383) | 3.00046403 |
| 29 | Insidious onset (HP:0003587) | 2.95742436 |
| 30 | Termporal pattern (HP:0011008) | 2.95742436 |
| 31 | Dysmetric saccades (HP:0000641) | 2.93314924 |
| 32 | Postural instability (HP:0002172) | 2.92933045 |
| 33 | Ankle clonus (HP:0011448) | 2.88342805 |
| 34 | Absent speech (HP:0001344) | 2.80599939 |
| 35 | Abnormal drinking behavior (HP:0030082) | 2.77832179 |
| 36 | Polydipsia (HP:0001959) | 2.77832179 |
| 37 | Truncal ataxia (HP:0002078) | 2.66481712 |
| 38 | Mutism (HP:0002300) | 2.64371628 |
| 39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.60470231 |
| 40 | Hyperventilation (HP:0002883) | 2.59192752 |
| 41 | Diplopia (HP:0000651) | 2.58056632 |
| 42 | Abnormality of binocular vision (HP:0011514) | 2.58056632 |
| 43 | J-shaped sella turcica (HP:0002680) | 2.52876720 |
| 44 | Slow saccadic eye movements (HP:0000514) | 2.52705141 |
| 45 | Psychosis (HP:0000709) | 2.51421275 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.50572287 |
| 47 | Confusion (HP:0001289) | 2.50516289 |
| 48 | Status epilepticus (HP:0002133) | 2.48383394 |
| 49 | Depression (HP:0000716) | 2.46874349 |
| 50 | Excessive salivation (HP:0003781) | 2.44238538 |
| 51 | Drooling (HP:0002307) | 2.44238538 |
| 52 | Exotropia (HP:0000577) | 2.43876253 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.40143781 |
| 54 | Clumsiness (HP:0002312) | 2.38020709 |
| 55 | Sensory axonal neuropathy (HP:0003390) | 2.37888810 |
| 56 | Epileptiform EEG discharges (HP:0011182) | 2.35335744 |
| 57 | Large for gestational age (HP:0001520) | 2.34917282 |
| 58 | Aplasia involving bones of the extremities (HP:0009825) | 2.34792275 |
| 59 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.34792275 |
| 60 | Aplasia of the phalanges of the hand (HP:0009802) | 2.34792275 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.34689619 |
| 62 | Lower limb muscle weakness (HP:0007340) | 2.34561501 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.33803079 |
| 64 | Anxiety (HP:0000739) | 2.33587132 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.29897399 |
| 66 | Hemiparesis (HP:0001269) | 2.28251667 |
| 67 | Congenital sensorineural hearing impairment (HP:0008527) | 2.28103937 |
| 68 | Postural tremor (HP:0002174) | 2.25982052 |
| 69 | Blue irides (HP:0000635) | 2.22864938 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.22398813 |
| 71 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.22224435 |
| 72 | Akinesia (HP:0002304) | 2.20208499 |
| 73 | Prolonged QT interval (HP:0001657) | 2.18992676 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.18113052 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17882692 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17344433 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17344433 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17344433 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 2.17228732 |
| 80 | Limb dystonia (HP:0002451) | 2.15978154 |
| 81 | EEG with generalized epileptiform discharges (HP:0011198) | 2.15218893 |
| 82 | Decreased subcutaneous fat (HP:0001002) | 2.14232991 |
| 83 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13831529 |
| 84 | Metabolic alkalosis (HP:0200114) | 2.11857622 |
| 85 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11681266 |
| 86 | Increased circulating renin level (HP:0000848) | 2.10458712 |
| 87 | Parakeratosis (HP:0001036) | 2.08842004 |
| 88 | Axonal loss (HP:0003447) | 2.07238421 |
| 89 | Syncope (HP:0001279) | 2.07021833 |
| 90 | Lower limb asymmetry (HP:0100559) | 2.05777447 |
| 91 | Abnormality of renin-angiotensin system (HP:0000847) | 2.04462763 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.02100937 |
| 93 | Abnormality of salivation (HP:0100755) | 2.01711116 |
| 94 | Ketoacidosis (HP:0001993) | 2.01024670 |
| 95 | Urinary urgency (HP:0000012) | 2.00949510 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 1.99390794 |
| 97 | Focal dystonia (HP:0004373) | 1.98648128 |
| 98 | Ventricular fibrillation (HP:0001663) | 1.98086409 |
| 99 | Polyuria (HP:0000103) | 1.96192223 |
| 100 | Widely spaced teeth (HP:0000687) | 1.95871108 |
| 101 | Hypomagnesemia (HP:0002917) | 1.94497822 |
| 102 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.93443143 |
| 103 | Thickened helices (HP:0000391) | 1.91748833 |
| 104 | Decreased circulating renin level (HP:0003351) | 1.90685164 |
| 105 | Spastic tetraparesis (HP:0001285) | 1.90663837 |
| 106 | Retinal dysplasia (HP:0007973) | 1.90385453 |
| 107 | Gait ataxia (HP:0002066) | 1.88312750 |
| 108 | Horizontal nystagmus (HP:0000666) | 1.87901851 |
| 109 | Inability to walk (HP:0002540) | 1.86360807 |
| 110 | Hypsarrhythmia (HP:0002521) | 1.85609196 |
| 111 | Clonus (HP:0002169) | 1.84876103 |
| 112 | Bulbous nose (HP:0000414) | 1.84510277 |
| 113 | Abnormality of saccadic eye movements (HP:0000570) | 1.84480811 |
| 114 | Torticollis (HP:0000473) | 1.83449335 |
| 115 | Urinary incontinence (HP:0000020) | 1.83150883 |
| 116 | Abnormal EKG (HP:0003115) | 1.83106805 |
| 117 | Poor eye contact (HP:0000817) | 1.82695406 |
| 118 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82606918 |
| 119 | Genetic anticipation (HP:0003743) | 1.80787465 |
| 120 | Rapidly progressive (HP:0003678) | 1.80102636 |
| 121 | Abnormal social behavior (HP:0012433) | 1.78891648 |
| 122 | Impaired social interactions (HP:0000735) | 1.78891648 |
| 123 | Abnormal urine output (HP:0012590) | 1.78360117 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77238849 |
| 125 | Lower limb amyotrophy (HP:0007210) | 1.76473212 |
| 126 | Conical tooth (HP:0000698) | 1.76468729 |
| 127 | Bowel incontinence (HP:0002607) | 1.74901739 |
| 128 | Hypothermia (HP:0002045) | 1.74197895 |
| 129 | Mask-like facies (HP:0000298) | 1.74138081 |
| 130 | Hemiplegia (HP:0002301) | 1.74103935 |
| 131 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74096535 |
| 132 | Stereotypic behavior (HP:0000733) | 1.73215033 |
| 133 | Sleep apnea (HP:0010535) | 1.72960041 |
| 134 | Bradykinesia (HP:0002067) | 1.72951549 |
| 135 | Rigidity (HP:0002063) | 1.70943156 |
| 136 | Amblyopia (HP:0000646) | 1.70645938 |
| 137 | Xanthomatosis (HP:0000991) | 1.69969928 |
| 138 | Cerebral hemorrhage (HP:0001342) | 1.69728638 |
| 139 | Megalencephaly (HP:0001355) | 1.68372835 |
| 140 | Abnormal large intestine physiology (HP:0012700) | 1.68261518 |
| 141 | Anosmia (HP:0000458) | 1.67192067 |
| 142 | Agitation (HP:0000713) | 1.66641747 |
| 143 | Pheochromocytoma (HP:0002666) | 1.66148211 |
| 144 | Hyperaldosteronism (HP:0000859) | 1.64853158 |
| 145 | Type II lissencephaly (HP:0007260) | 1.63742480 |
| 146 | Glomerulonephritis (HP:0000099) | 1.62538548 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.61177883 |
| 148 | Decreased central vision (HP:0007663) | 1.60216720 |
| 149 | Hyperthyroidism (HP:0000836) | 1.59128334 |
| 150 | Keratoconus (HP:0000563) | 1.58870026 |
| 151 | Increased corneal curvature (HP:0100692) | 1.58870026 |
| 152 | Abnormality of the renal cortex (HP:0011035) | 1.58068996 |
| 153 | Abnormality of renal excretion (HP:0011036) | 1.55546221 |
| 154 | Fragile nails (HP:0001808) | 1.54827491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.32442114 |
| 2 | EPHA4 | 3.76629624 |
| 3 | NTRK3 | 3.33564678 |
| 4 | STK39 | 3.12046061 |
| 5 | PRPF4B | 2.73574870 |
| 6 | ADRBK2 | 2.51468040 |
| 7 | INSRR | 2.48845818 |
| 8 | OXSR1 | 2.48256836 |
| 9 | EPHB1 | 2.41333616 |
| 10 | RIPK4 | 2.35218330 |
| 11 | CASK | 2.34755322 |
| 12 | WNK3 | 2.34508454 |
| 13 | MAP3K9 | 2.16731377 |
| 14 | FES | 2.03300897 |
| 15 | TNIK | 2.01151559 |
| 16 | NTRK1 | 1.99164245 |
| 17 | CAMKK2 | 1.93311719 |
| 18 | GRK1 | 1.89924581 |
| 19 | DAPK2 | 1.72691692 |
| 20 | MAP3K4 | 1.71625788 |
| 21 | PKN1 | 1.67001503 |
| 22 | PAK6 | 1.66113524 |
| 23 | PINK1 | 1.63192642 |
| 24 | KSR2 | 1.59507491 |
| 25 | TIE1 | 1.54890198 |
| 26 | TYRO3 | 1.51203173 |
| 27 | WNK1 | 1.50175478 |
| 28 | MAP3K13 | 1.47691020 |
| 29 | CAMK2B | 1.47277630 |
| 30 | ERN1 | 1.39909113 |
| 31 | EPHA3 | 1.39235204 |
| 32 | MARK1 | 1.38787300 |
| 33 | CDK5 | 1.37577018 |
| 34 | PRKD3 | 1.34107018 |
| 35 | ARAF | 1.33522044 |
| 36 | MAP2K7 | 1.32408072 |
| 37 | CDK19 | 1.29042805 |
| 38 | MINK1 | 1.27688850 |
| 39 | MAPKAPK5 | 1.25943975 |
| 40 | CAMKK1 | 1.25341759 |
| 41 | BRD4 | 1.22932554 |
| 42 | BMPR2 | 1.21938618 |
| 43 | PNCK | 1.21786079 |
| 44 | GRK7 | 1.21660485 |
| 45 | GRK5 | 1.21603078 |
| 46 | NTRK2 | 1.20921478 |
| 47 | WNK4 | 1.18889903 |
| 48 | UHMK1 | 1.16108181 |
| 49 | ADRBK1 | 1.11347607 |
| 50 | MAP3K2 | 1.08550948 |
| 51 | CAMK2A | 1.07261453 |
| 52 | MAPK13 | 1.06677358 |
| 53 | SGK494 | 1.02732184 |
| 54 | SGK223 | 1.02732184 |
| 55 | PDPK1 | 1.01128128 |
| 56 | MAPK15 | 1.00839976 |
| 57 | STK11 | 1.00191616 |
| 58 | FGR | 0.98355141 |
| 59 | SGK2 | 0.97792844 |
| 60 | MAP2K4 | 0.96337974 |
| 61 | MARK2 | 0.95857456 |
| 62 | NEK6 | 0.94732017 |
| 63 | CSNK1G2 | 0.94229957 |
| 64 | BMPR1B | 0.93990486 |
| 65 | KSR1 | 0.92674339 |
| 66 | MAP2K6 | 0.92284732 |
| 67 | SIK2 | 0.90316463 |
| 68 | PLK2 | 0.89653546 |
| 69 | CAMK2D | 0.86570276 |
| 70 | PHKG1 | 0.85181330 |
| 71 | PHKG2 | 0.85181330 |
| 72 | PRKCZ | 0.84538579 |
| 73 | TXK | 0.84110774 |
| 74 | PRKD2 | 0.83150204 |
| 75 | BCR | 0.82366303 |
| 76 | PRKCG | 0.82333596 |
| 77 | PRKCQ | 0.79223265 |
| 78 | PDK1 | 0.77403489 |
| 79 | CSNK1G3 | 0.76053627 |
| 80 | PTK6 | 0.75756709 |
| 81 | PTK2B | 0.75752178 |
| 82 | CSNK1A1L | 0.75133963 |
| 83 | CDK14 | 0.74924777 |
| 84 | CDK15 | 0.72248183 |
| 85 | ITK | 0.71942673 |
| 86 | CAMK2G | 0.71883132 |
| 87 | SGK1 | 0.71852914 |
| 88 | PRKD1 | 0.71031615 |
| 89 | PRKCA | 0.70657165 |
| 90 | FYN | 0.69694097 |
| 91 | MAP2K1 | 0.69581207 |
| 92 | PRKG2 | 0.69058588 |
| 93 | CDK18 | 0.69055134 |
| 94 | ICK | 0.68484190 |
| 95 | CAMK1G | 0.67841725 |
| 96 | PRKCE | 0.65944332 |
| 97 | MAP3K1 | 0.64106056 |
| 98 | CDK11A | 0.63447450 |
| 99 | ROCK2 | 0.63108997 |
| 100 | ACVR1B | 0.62894867 |
| 101 | PRKACA | 0.61341774 |
| 102 | MAPKAPK3 | 0.61304777 |
| 103 | MOS | 0.60852597 |
| 104 | DAPK1 | 0.58609434 |
| 105 | TLK1 | 0.58308186 |
| 106 | PDGFRB | 0.57578505 |
| 107 | PAK3 | 0.57274599 |
| 108 | CAMK4 | 0.56572751 |
| 109 | DMPK | 0.55886584 |
| 110 | CAMK1 | 0.55406959 |
| 111 | PRKG1 | 0.54479016 |
| 112 | FGFR2 | 0.54268630 |
| 113 | PRKCH | 0.53928565 |
| 114 | CSNK1A1 | 0.53775766 |
| 115 | STK38 | 0.53591491 |
| 116 | TNK2 | 0.53358454 |
| 117 | RET | 0.52308179 |
| 118 | CDK3 | 0.52064110 |
| 119 | MAPK12 | 0.51754980 |
| 120 | AKT3 | 0.51178986 |
| 121 | LMTK2 | 0.49125225 |
| 122 | FGFR3 | 0.48986048 |
| 123 | DYRK1A | 0.48279474 |
| 124 | TRPM7 | 0.48217630 |
| 125 | PRKCB | 0.47716310 |
| 126 | PRKAA2 | 0.47023576 |
| 127 | PRKACG | 0.45110873 |
| 128 | PRKAA1 | 0.44308912 |
| 129 | CSNK1G1 | 0.44093981 |
| 130 | MAP2K2 | 0.43657188 |
| 131 | RPS6KA3 | 0.43273924 |
| 132 | RAF1 | 0.42463455 |
| 133 | TAOK1 | 0.41662006 |
| 134 | MAP3K12 | 0.41456680 |
| 135 | MAPK7 | 0.40050959 |
| 136 | PASK | 0.39054209 |
| 137 | CSNK1D | 0.39040083 |
| 138 | MAP3K7 | 0.38858919 |
| 139 | SGK3 | 0.37771311 |
| 140 | HIPK2 | 0.37481084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.93800844 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.84298874 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.81098222 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42405577 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41433243 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.39207970 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36080898 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27270200 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.24956851 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13585629 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.04261846 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.96075949 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.81712765 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79746351 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76730069 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.75035200 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74663277 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72618857 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.61006816 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59068219 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58584808 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.55864132 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53787884 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.51841159 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47354605 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46874990 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.45967877 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.43628578 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42411823 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38804629 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.34943020 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34242619 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32467408 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28525429 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23305208 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.19569742 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19548835 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19519280 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17872884 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17228013 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.14542494 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12556707 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10449738 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10438882 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10143978 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07611896 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.07467906 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07284790 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04147554 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03783380 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03305681 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02812106 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02014264 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00671589 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00041346 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96659869 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95272092 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94323608 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.93814847 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93283975 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93201413 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92521193 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91586860 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88513454 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88177308 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88038750 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87748217 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86606932 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84613366 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.82405842 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81570875 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81219832 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81163133 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79507360 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78844039 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.77708953 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.76961093 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76665935 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76605689 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76294592 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75824806 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75767499 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.74733586 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74170976 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.72742055 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72527210 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71787933 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71163494 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70835078 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70490900 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70229014 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67847750 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67839950 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66998680 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64478736 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63111015 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62721924 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61874312 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61421182 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.60408560 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60262904 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59417228 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59129302 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57394248 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56137457 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56047421 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55364871 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54970423 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54407560 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53524326 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53067749 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53004145 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51730538 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50818533 |
| 115 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49750758 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49252848 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49183780 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47343202 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47072140 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46913111 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46886052 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46111822 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45879068 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.45531562 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45388087 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44963807 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.44325937 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44105561 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.44078196 |
| 130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42550307 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42478107 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.41634440 |
| 133 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40051734 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39352870 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38489741 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37613396 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35636440 |
| 138 | Salmonella infection_Homo sapiens_hsa05132 | 0.34419802 |
| 139 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30581480 |
| 140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28368260 |

